Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 USA Mineral Supplements Market, by Sales Channel
1.4.2 USA Mineral Supplements Market, by Formulation
1.4.3 USA Mineral Supplements Market, by Application
1.4.4 USA Mineral Supplements Market, by End-use
1.4.5 USA Mineral Supplements Market, by Product
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Opportunities
2.2.3 Market Restraints
2.2.4 Market Challenges
2.2.5 Market Trends
2.3 Porter Five Forces Analysis
Chapter 3. Strategies Deployed in Mineral Supplements Market.
Chapter 4. US Mineral Supplements Market
4.1 US Mineral Supplements Market by Sales Channel
4.2 US Mineral Supplements Market by Formulation
4.3 US Mineral Supplements Market by Application
4.4 US Mineral Supplements Market by End-use
4.5 US Mineral Supplements Market by Product
Chapter 5. Company Profiles – Global Leaders
5.1 Glanbia PLC
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental and Regional Analysis
5.1.4 Research & Development Expenses
5.1.5 SWOT Analysis
5.2 Nestle S.A
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.2.5 Recent strategies and developments:
5.2.5.1 Partnerships, Collaborations, and Agreements:
5.2.5.2 Acquisition and Mergers:
5.2.6 SWOT Analysis
5.3 Herbalife Nutrition Ltd.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Product Launches and Product Expansions:
5.3.5 SWOT Analysis
5.4 Sanofi S.A.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent strategies and developments:
5.4.5.1 Acquisition and Mergers:
5.4.6 SWOT Analysis
5.5 Amway Corporation
5.5.1 Company Overview
5.5.2 Recent strategies and developments:
5.5.2.1 Partnerships, Collaborations, and Agreements:
5.5.2.2 Product Launches and Product Expansions:
5.5.3 SWOT Analysis
5.6 Bayer AG
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expense
5.6.5 Recent strategies and developments:
5.6.5.1 Product Launches and Product Expansions:
5.6.6 SWOT Analysis
5.7 Omega Protein Corporation (Cooke, Inc.)
5.7.1 Company Overview
5.7.2 SWOT Analysis
5.8 Pharmavite LLC (Otsuka Pharmaceutical Co., Ltd.) (Otsuka Holdings Co. Ltd)
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental & Regional Analysis
5.8.4 Research & Development Expense
5.8.5 SWOT Analysis
5.9 Koninklijke DSM N.V.
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental and Regional Analysis
5.9.4 Research & Development Expense
5.9.5 Recent strategies and developments:
5.9.5.1 Acquisition and Mergers:
5.9.6 SWOT Analysis
5.10. Nu Skin Enterprises, Inc.
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental Analysis
5.10.4 Research & Development Expenses
5.10.5 SWOT Analysis
Unique Offerings 